Jazz' $700 million EUSA buy diversifies portfolio and broadens reach
This article was originally published in Scrip
Executive Summary
Jazz Pharmaceuticals PLC will increase its international presence and diversify its specialty pharma portfolio with the $700 million purchase of EUSA Pharma.